SKA2 and breast carcinoma: Recent evidences showed that overexpression of SKA2 promoted proliferation and human breast cancer progression, whereas SKA2 knockdown in human lung epithelial cells reduced transactivation and suppressed dexamethasone inhibition of proliferation [36, 37].